Diagnosis and treatment of adults with congenital heart disease

Robert J Henning1

  • 1School of Public Health, University of South Florida, Tampa, FL 33612, USA.

Future Cardiology
|April 17, 2020
PubMed

Insights

Congenital heart disease (CHD) affects 50 million adults, increasing risks for other conditions and requiring greater healthcare. This paper reviews diagnosis and treatment for common adult CHD types.

Area of Science:

  • Cardiology
  • Adult Congenital Heart Disease
  • Public Health

Background:

  • Approximately 50 million adults globally live with congenital heart disease (CHD).
  • Common adult CHD types include atrial septal defects, ventricular septal defects, and tetralogy of Fallot.
  • Adults with CHD face higher risks of hypertension, vascular disease, diabetes, and kidney disease.

Purpose of the Study:

  • To discuss the diagnosis and treatment of common congenital heart defects in adults.
  • To highlight the increased health risks and healthcare needs of adults with CHD.

Main Methods:

  • Literature review of diagnostic and treatment modalities for adult CHD.
  • Analysis of epidemiological data on CHD prevalence and associated comorbidities.

Main Results:

  • Adults with CHD have a significantly higher prevalence of comorbidities compared to controls.
  • By age 50, over 10% of adults with CHD experience cardiac dysrhythmias, and 4% face sudden death.
  • Healthcare utilization is two to four times greater for adults with CHD.

Conclusions:

  • Effective diagnosis and management are crucial for adults with CHD.
  • Addressing comorbidities and long-term risks is essential for improving outcomes in adult CHD patients.
  • Specialized lifelong care is necessary for the growing adult CHD population.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
228
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
282
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
218
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
339
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
237
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
178